Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ryne Marshall is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for pancreatic cancer treatment. His most impactful work centers on comparing surgical approaches for pancreatic ductal adenocarcinoma, particularly through the landmark DIPLOMA study. This international multicenter analysis, which has garnered 280 citations, rigorously compared oncological outcomes between minimally invasive distal pancreatectomy (MIDP) and open distal pancreatectomy (ODP) in patients with pancreatic cancer. Dr. Marshall’s research has been instrumental in demonstrating that while MIDP offers superior short-term recovery benefits, careful patient selection remains critical to ensure comparable oncological safety. His contributions have helped shape modern pancreatic surgery guidelines, providing evidence-based insights that balance surgical innovation with cancer control. By addressing the fundamental question of whether minimally invasive approaches compromise long-term outcomes, Dr. Marshall has influenced clinical practice worldwide. His work continues to drive the evolution of pancreatic surgery, offering patients less invasive options without sacrificing the rigor required for effective cancer treatment.